Delivery Order SPE2DB25D2204-SPE2DB25FTGXN
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,728.17 to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Venclexta 100 mg tablets in quantities of 120 units. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 13, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen Drug Corp's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Venclexta 100 mg tablets (120-count units) with a contract ceiling value of $9,728.17. This is a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Venclexta 100 mg tablets (120-count units) under a firm fixed-price contract valued at $9.7K. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9M through December 2026. The award was made through open competition with no set-aside designation....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $9,728.17 to supply Venclexta 100 mg tablets (120-count units) with an ultimate completion date of September 9, 2025. This is a firm fixed-price, non-set-aside delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical products will be delivered to...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $9,728.17 by the Defense Logistics Agency (DLA) for the supply of Venclexta 100 mg tablets (120-count units), with a firm fixed price structure and an ultimate completion date of September 2, 2025. This competitively awarded, non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Venclexta 100 mg tablets in quantities of 120 units. This firm fixed price delivery order, valued at $58,369.02, represents a non-competitive, non-set-aside award and is scheduled for completion by August 14, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Venclexta 100 mg tablets (quantity: 120 units) under a firm fixed-price contract valued at $9,728.17. This is a non-set-aside competitive award with an ultimate completion date of August 20, 2025, and performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $9,728.17 delivery order to AmerisourceBergen Drug Corp for Venclexta 100 mg tablets (120-count units) under a firm fixed-price contract. The order, issued on August 19, 2025, with completion targeted for September 10, 2025, represents a direct procurement of this specialized pharmaceutical product to support federal medical supply requirements. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Venclexta 50 mg tablet unit dose packages (quantity 7). This non-set-aside, competitively awarded contract is valued at $1,743.06 with a firm fixed price and is scheduled for completion by September 4, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120-count units) under a firm fixed-price arrangement. The contract, valued at $9,728.17, is scheduled for completion by August 11, 2025, and was awarded on July 21, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance. This delivery order represents a competitively awarded, non-set-aside contract...
- SPE2DB25D2204Indefinite Delivery Contract
- SPE2DB25D2204-SPE2DB25FTGXNDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,728.17 to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120 count) on August 21, 2025, with an ultimate completion date of September 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through competitive federal procurement. The company's extensive contract portfolio with DLA demonstrates its capability to fulfill diverse medical supply requirements across multiple therapeutic domains, from specialty medications to generic drugs and medical devices. This delivery order for Venclexta, a specialized oncology medication, exemplifies the breadth of pharmaceutical products the company provides through its prime vendor relationship with DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.7k | 8/21/25 |